174 related articles for article (PubMed ID: 38407942)
21. Knockout of c-Cbl slows EGFR endocytic trafficking and enhances EGFR signaling despite incompletely blocking receptor ubiquitylation.
Crotchett BLM; Ceresa BP
Pharmacol Res Perspect; 2021 Apr; 9(2):e00756. PubMed ID: 33811466
[TBL] [Abstract][Full Text] [Related]
22. Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.
Kadera BE; Toste PA; Wu N; Li L; Nguyen AH; Dawson DW; Donahue TR
Clin Cancer Res; 2015 Jan; 21(1):157-65. PubMed ID: 25348515
[TBL] [Abstract][Full Text] [Related]
23. Threshold-controlled ubiquitination of the EGFR directs receptor fate.
Sigismund S; Algisi V; Nappo G; Conte A; Pascolutti R; Cuomo A; Bonaldi T; Argenzio E; Verhoef LG; Maspero E; Bianchi F; Capuani F; Ciliberto A; Polo S; Di Fiore PP
EMBO J; 2013 Jul; 32(15):2140-57. PubMed ID: 23799367
[TBL] [Abstract][Full Text] [Related]
24. A tale of two Cbls: interplay of c-Cbl and Cbl-b in epidermal growth factor receptor downregulation.
Pennock S; Wang Z
Mol Cell Biol; 2008 May; 28(9):3020-37. PubMed ID: 18316398
[TBL] [Abstract][Full Text] [Related]
25. Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma.
Hong SY; Lu YC; Hsiao SH; Kao YR; Lee MH; Lin YP; Wang CY; Wu CW
Oncogene; 2022 Mar; 41(13):1907-1917. PubMed ID: 35149839
[TBL] [Abstract][Full Text] [Related]
26. Balancing Protein Stability and Activity in Cancer: A New Approach for Identifying Driver Mutations Affecting CBL Ubiquitin Ligase Activation.
Li M; Kales SC; Ma K; Shoemaker BA; Crespo-Barreto J; Cangelosi AL; Lipkowitz S; Panchenko AR
Cancer Res; 2016 Feb; 76(3):561-71. PubMed ID: 26676746
[TBL] [Abstract][Full Text] [Related]
27. CGRRF1, a growth suppressor, regulates EGFR ubiquitination in breast cancer.
Lee YJ; Ho SR; Graves JD; Xiao Y; Huang S; Lin WC
Breast Cancer Res; 2019 Dec; 21(1):134. PubMed ID: 31801577
[TBL] [Abstract][Full Text] [Related]
28. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
Odintsova E; van Niel G; Conjeaud H; Raposo G; Iwamoto R; Mekada E; Berditchevski F
J Biol Chem; 2013 Sep; 288(36):26323-26334. PubMed ID: 23897813
[TBL] [Abstract][Full Text] [Related]
29. Antagonizing c-Cbl enhances EGFR-dependent corneal epithelial homeostasis.
Rush JS; Boeving MA; Berry WL; Ceresa BP
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4691-9. PubMed ID: 24985478
[TBL] [Abstract][Full Text] [Related]
30. β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway.
Deng M; Liu B; Song H; Yu R; Zou D; Chen Y; Ma Y; Lv F; Xu L; Zhang Z; Lv Q; Yang X; Che X; Qu X; Liu Y; Zhang Y; Hu X
Phytomedicine; 2020 Apr; 69():153184. PubMed ID: 32199253
[TBL] [Abstract][Full Text] [Related]
31. LncRNA DUXAP9-206 directly binds with Cbl-b to augment EGFR signaling and promotes non-small cell lung cancer progression.
Zhu T; An S; Choy MT; Zhou J; Wu S; Liu S; Liu B; Yao Z; Zhu X; Wu J; He Z
J Cell Mol Med; 2019 Mar; 23(3):1852-1864. PubMed ID: 30515972
[TBL] [Abstract][Full Text] [Related]
32. ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.
Jansen SM; Sleumer LS; Damen E; Meijer IM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2009 May; 21(5):810-8. PubMed ID: 19263517
[TBL] [Abstract][Full Text] [Related]
33. Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation.
Umebayashi K; Stenmark H; Yoshimori T
Mol Biol Cell; 2008 Aug; 19(8):3454-62. PubMed ID: 18508924
[TBL] [Abstract][Full Text] [Related]
34. CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.
Calco GN; Stephens OR; Donahue LM; Tsui CC; Pierchala BA
J Biol Chem; 2014 Mar; 289(11):7307-19. PubMed ID: 24425877
[TBL] [Abstract][Full Text] [Related]
35. CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation.
Chang CC; Yang MH; Lin BR; Chen ST; Pan SH; Hsiao M; Lai TC; Lin SK; Jeng YM; Chu CY; Chen RH; Yang PC; Chin YE; Kuo ML
Cell Death Differ; 2013 Mar; 20(3):443-55. PubMed ID: 23175185
[TBL] [Abstract][Full Text] [Related]
36. CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies.
Schroeder B; Srivatsan S; Shaw A; Billadeau D; McNiven MA
Mol Biol Cell; 2012 Sep; 23(18):3602-11. PubMed ID: 22833562
[TBL] [Abstract][Full Text] [Related]
37. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages.
Smirnova T; Bonapace L; MacDonald G; Kondo S; Wyckoff J; Ebersbach H; Fayard B; Doelemeyer A; Coissieux MM; Heideman MR; Bentires-Alj M; Hynes NE
Oncotarget; 2016 Dec; 7(50):82289-82304. PubMed ID: 27793045
[TBL] [Abstract][Full Text] [Related]
38. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
39. Cbl and Cbl-b independently regulate EGFR through distinct receptor interaction modes.
Pinilla-Macua I; Sorkin A
Mol Biol Cell; 2023 Dec; 34(13):ar134. PubMed ID: 37903221
[TBL] [Abstract][Full Text] [Related]
40. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
